Medtronic sees recovery in elective procedures, beats Wall Street estimates

Medtronic reported better-than-expected sales and earnings for its fiscal fourth quarter as the Covid-19 pandemic eased in key markets, allowing patients to resume medical procedures that had been put off due to public-health concerns.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.